Participant characteristics
| . | n (%) . |
|---|---|
| Total participants | 481 |
| Sex | |
| Male | 108 (22.5) |
| Female | 371 (77.1) |
| Participants with VWF:Ag | 478 (99.4) |
| Participants with VWF:RCo | 401(83.4) |
| Participants with VWF:GpIbM | 38 (7.9) |
| Participants with information on estrogen use | 459 |
| No use at either time point | 343 (74.7) |
| Use at both time points | 32 (7.0) |
| Use at first time point only | 23 (5.0) |
| Use at second time point only | 61 (13.3) |
| Initial VWF:Ag >100% | 182/478 (38) |
| Initial VWF:RCo >100% | 101/401 (25) |
| Initial VWF:GpIbM >100% | 13/38 (34) |
| . | n (%) . |
|---|---|
| Total participants | 481 |
| Sex | |
| Male | 108 (22.5) |
| Female | 371 (77.1) |
| Participants with VWF:Ag | 478 (99.4) |
| Participants with VWF:RCo | 401(83.4) |
| Participants with VWF:GpIbM | 38 (7.9) |
| Participants with information on estrogen use | 459 |
| No use at either time point | 343 (74.7) |
| Use at both time points | 32 (7.0) |
| Use at first time point only | 23 (5.0) |
| Use at second time point only | 61 (13.3) |
| Initial VWF:Ag >100% | 182/478 (38) |
| Initial VWF:RCo >100% | 101/401 (25) |
| Initial VWF:GpIbM >100% | 13/38 (34) |
| . | n (SD) . |
|---|---|
| Mean age, y | |
| First laboratory time point | 11 (5.5) |
| Second laboratory time point | 12.3 (5.5) |
| Average time between laboratory draws, d | 467 (794) |
| Median hemoglobin first time point, g/dL | 11.6 (2.7) |
| Median hemoglobin second time point, g/dL | 12.6 (2.3) |
| Median change in hemoglobin between draws, g/dL | 0.9 (2.6) (range, −6.5 to 11.0) |
| . | n (SD) . |
|---|---|
| Mean age, y | |
| First laboratory time point | 11 (5.5) |
| Second laboratory time point | 12.3 (5.5) |
| Average time between laboratory draws, d | 467 (794) |
| Median hemoglobin first time point, g/dL | 11.6 (2.7) |
| Median hemoglobin second time point, g/dL | 12.6 (2.3) |
| Median change in hemoglobin between draws, g/dL | 0.9 (2.6) (range, −6.5 to 11.0) |
SD, standard deviation.